Xinxiang Tuoxin Pharmaceutical Co.,Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 777.81 million compared to CNY 500.26 million a year ago. Revenue was CNY 784.72 million compared to CNY 502.48 million a year ago.

Net income was CNY 286.54 million compared to CNY 65.71 million a year ago. Basic earnings per share from continuing operations was CNY 2.27 compared to CNY 0.66 a year ago. Diluted earnings per share from continuing operations was CNY 2.27 compared to CNY 0.66 a year ago.